SDZ.SW stock up after FY2025 biosimilars surge on SIX intraday: 1-year upside 24.30%
SDZ.SW stock trading CHF65.64 on SIX intraday after biosimilars-driven FY2025 results; Meyka AI projects CHF81.59 (24.30% upside).
SDZ.SW stock trading CHF65.64 on SIX intraday after biosimilars-driven FY2025 results; Meyka AI projects CHF81.59 (24.30% upside).
NVDA stock today: Nvidia beats Q4, guides Q1 revenue to US$78B, and starts shipping Vera Rubin AI systems. What it means for Singapore investors, pricing, risks, and key levels.
3695.T stock closed ¥1,709 on 26 Feb 2026; we assess AI exposure, valuation, and a ¥2,577 model target for investors
8059.HK stock fell 22.50% to HK$0.031 at close 26 Feb 2026. Quick view of drivers, valuation, Meyka AI grade and forecast for investors.
ETG.DE stock jumps 46.07% intraday to €26.00 on 26 Feb 2026; technical momentum high, valuation and forecasts raise caution
MSFT stock today: What Trump’s SOTU tech policy on AI power costs and tariffs means for Microsoft and HK investors, with valuation, technicals, and key dates.
Pre-market note on ENB-PFA.TO stock at C$71.80 with heavy volume, valuation, technicals, and Meyka AI forecast.
TEM.AX stock closed A$0.006 on 26 Feb 2026; Meyka AI sees A$0.01 near-term upside and flags liquidity and valuation risks
First Solar stock drops about 16% after a weak 2026 sales outlook and tariff uncertainty. We break down guidance, policy risks, valuation, and key levels US investors should watch.
AURI stock at $0.0002 ahead of March 2 earnings; Meyka AI forecasts -51.46% vs current price